European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres
Authors:
- A Della RossaARA Della Rossa
- G ValentiniGVG Valentini
- S BombardieriSBS Bombardieri
- W BencivelliWBW Bencivelli
- A J SilmanASA J Silman
- S D'ANgeloSDS D'ANgelo
- M Matucci CerinicMCM Matucci Cerinic
- J F BelchJ F Belch
- C M BlackCBC M Black
- R BecvarRBR Becvar
- P BruhlmanPBP Bruhlman
- F CozziFCF Cozzi
Open Access
- 1 June 2001
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (6) , 585-591
Abstract
OBJECTIVE To investigate the existence of differences among European referral centres for systemic sclerosis (SSc) in the pattern of attendance and referral and in the clinical and therapeutical approaches. METHODS In 1995 the European Scleroderma Study Group initiated a multicentre prospective one year study whose aim was to define the disease activity criteria in SSc. During the study period each participating European centre was asked to enrol consecutive patients satisfying American College of Rheumatology criteria for SSc and to fill out for each of them a standardised clinical chart. Patients from various centres were compared and differences in epidemiological, clinical, and therapeutical aspects were analysed. RESULTS Nineteen different medical research centres consecutively recruited 290 patients. The patients could be divided into two subgroups: 173 with the limited (lSSc) and 117 with the diffuse (dSSc) form of the disease. The clinical and serological findings for the series of 290 patients seemed to be similar to data previously reported. However, when the data were analysed to elicit any differences between the participating centres, a high degree of variability emerged, in both epidemiological and clinical features and in the diagnostic and therapeutic approaches to the disease. CONCLUSIONS The clinical approach to SSc, not only in different countries but also in different centres within the same country, is not yet standardised. To overcome this problem, it will be necessary for the scientific community to draw up a standardised procedure for the management of patients with SSc. This would provide a common research tool for different centres engaged in research on this complex disease.Keywords
This publication has 23 references indexed in Scilit:
- Scleroderma Renal Crisis Analysis of Prevalence and Outcome in a Large Italian SeriesJCR: Journal of Clinical Rheumatology, 1997
- A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopyAustralian and New Zealand Journal of Medicine, 1995
- THE MANAGEMENT OF SYSTEMIC SCLEROSISRheumatology, 1995
- Therapy for severe interstitial lung disease in systemic sclerosis. a retrospective studyArthritis & Rheumatism, 1994
- Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamideArthritis & Rheumatism, 1994
- Clinical and Prognostic Associations Based on Serum Antinuclear Antibodies in Japanese Patients with Systemic SclerosisArthritis & Rheumatism, 1994
- Skin score: A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosisArthritis & Rheumatism, 1990
- ORGAN MANIFESTATIONS IN 100 PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS: A COMPARISON BETWEEN THE CREST SYNDROME AND DIFFUSE SCLERODERMARheumatology, 1989
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980